These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7080212)

  • 21. Preliminary experience with combined therapy using rifampicin and isoprodian (L73A).
    Freerksen E
    Lepr Rev; 1975 Jun; 46(2 Suppl):161-3. PubMed ID: 1165695
    [No Abstract]   [Full Text] [Related]  

  • 22. Rifampicin and isoprodian in combination in the treatment of leprosy.
    Depasquale G
    Lepr Rev; 1975 Jun; 46(2 Suppl):179-80. PubMed ID: 1100958
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of leprosy with rifampicin and isoprodian (L73A).
    Terencio de las Aguas J
    Lepr Rev; 1975 Jun; 46(2 Suppl):165-8. PubMed ID: 1100956
    [No Abstract]   [Full Text] [Related]  

  • 24. [Bacteriostatic activity of blood in single and combined use of ethionamide or prothionamide].
    Kozulitsyna TI; Korotaev GA
    Probl Tuberk; 1975; (5):70-3. PubMed ID: 1144350
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of DDS with two combined chemotherapy regimens for multibacillary leprosy. Results after 3 years of treatment. A prospective randomized multicentre study.
    Dietrich M; Wabitsch R
    Lepr Rev; 1986; 57 Suppl 3():60-2. PubMed ID: 3573962
    [No Abstract]   [Full Text] [Related]  

  • 26. Preliminary experience with rifampicin and isoprodian (L73A)--combination in lepromatous leprosy.
    Hamzah M; Kosasih A
    Lepr Rev; 1975 Jun; 46(2 Suppl):181-7. PubMed ID: 1100959
    [No Abstract]   [Full Text] [Related]  

  • 27. On the mechanism of the antimycobacterial activity of isoniazid + prothionamide + dapsone (Isoprodian).
    Urbanczik R
    Chemotherapy; 1979; 25(5):261-7. PubMed ID: 477453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Report of combined therapy in leprosy with rifampicin and isoprodian conducted at the Bisidimo-center, Ethiopia.
    Rohde R
    Lepr Rev; 1975 Jun; 46(2 Suppl):199-205. PubMed ID: 1100961
    [No Abstract]   [Full Text] [Related]  

  • 29. Preliminary experience with rifampicin and isoprodian in combination in leprosy treatment.
    Krenzien HN
    Lepr Rev; 1975 Jun; 46(2 Suppl):189-98. PubMed ID: 1100960
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of leprosy with rifampicin and isoprodian in 38 patients at St. Thomas Hospital, Chetput, Sout India.
    Aschhoff M
    Lepr Rev; 1975 Jun; 46(2 Suppl):173-8. PubMed ID: 1165697
    [No Abstract]   [Full Text] [Related]  

  • 31. [Haematological effects of isoprodian (author's transl)].
    Peters M; Papageogiou A
    Prax Pneumol; 1976 Jul; 30(7):430-4. PubMed ID: 967820
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effectiveness of treatment with rifampicin and isoniazid in association with ethambutol or prothionamide in patients with recently detected pulmonary tuberculosis].
    Homenko AG; Ciukanov VL
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(4):211-8. PubMed ID: 232302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of lepromatous Hansen disease with a rifampicine-isoprodian association (author's transl)].
    Colin M; de Montaigne E
    Med Trop (Mars); 1980; 40(2):157-9. PubMed ID: 6991851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New drugs in the treatment of leprosy].
    De Las Aguas JT
    Med Cutan Ibero Lat Am; 1976; 4(5):365-70. PubMed ID: 1035391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does isoniazid increase the hepatotoxicity of the combination prothionamide-dapsone? Isoprodian Study Group.
    Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):536-41. PubMed ID: 1299708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary tuberculosis treated with isoprodian and rifampicin or pyrazinamide.
    Kleeberg HH
    Chemotherapy; 1987; 33(3):219-28. PubMed ID: 3297528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of open cavernous pulmonary tuberculosis (author's transl)].
    Kittel H
    Dtsch Med Wochenschr; 1979 Mar; 104(13):477-9. PubMed ID: 436602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comments on an editorial by B. R. Chatterjee "On Multi-Drug Combinations in the Treatment of Leprosy".
    Grosset JH; Baohang J; Noordeen SK
    Indian J Lepr; 1989 Jul; 61(3):323-7. PubMed ID: 2768880
    [No Abstract]   [Full Text] [Related]  

  • 39. Isoprodian and rifampicin in the treatment of leprosy: a descriptive evaluation of therapy durations in 475 Paraguayan leprosy patients.
    Pritze S; Alvarenga AE; Leguizamon O; Haubitz I
    Chemotherapy; 1989; 35(5):373-82. PubMed ID: 2676405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of two regimens of combined chemotherapy of one year duration in multibacillary leprosy. Results after four and five years' follow-up.
    Pattyn SR; André PS; Ferracci C; Baquillon G
    Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):297-303. PubMed ID: 6541198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.